TargetMol

Lissoclinamide 4

Product Code:
 
TAR-T32792
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T32792-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T32792-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Lissoclinamide 4 is a novel cyclic peptide with cytotoxic activity from the ascidian Lissoclinum patella.
CAS:
120853-16-9
Molecular Weight:
741.92
Purity:
0.98
SMILES:
O=C1N2[C@](C3=N[C@@]([C@@H](C)O3)(C(=O)N[C@@H](C(C)C)C4=N[C@@](CS4)(C(=O)N[C@H](CC5=CC=CC=C5)C6=NC(C(=O)N[C@H]1CC7=CC=CC=C7)=CS6)[H])[H])(CCC2)[H]

References

Rashid MA, Gustafson KR, Cardellina JH 2nd, Boyd MR. Patellamide F, A new cytotoxic cyclic peptide from the colonial ascidian Lissoclinum patella. J Nat Prod. 1995 Apr;58(4):594-7. PubMed PMID: 7623037. Degnan BM, Hawkins CJ, Lavin MF, McCaffrey EJ, Parry DL, van den Brenk AL, Watters DJ. New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella. J Med Chem. 1989 Jun;32(6):1349-54. PubMed PMID: 2724305. Hawkins CJ, Lavin MF, Marshall KA, van den Brenk AL, Watters DJ. Structure-activity relationships of the lissoclinamides: cytotoxic cyclic peptides from the ascidian Lissoclinum patella. J Med Chem. 1990 Jun;33(6):1634-8. PubMed PMID: 2342056.